Abstract:DNA methyltransferase 1 (DNMT1) is the primary enzyme responsible for maintaining DNA methylation patterns during cellular division, crucial for cancer development by suppressing tumor suppressor genes. In this study, we retained the phthalimide structure of N -phthaloyl-L-tryptophan (RG108) and substituted its indole ring with nitrogen-containing aromatic rings of varying sizes. We synthesized 3-(9 H -carbazol-9-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoic acids and confirmed them as DNMT1 inhibitors through protein affinity testing, radiometric method using tritium labeled SAM, and MTT assay. Preliminary structure-activity relationship analysis revealed that introducing substituents on the carbazole ring could enhance inhibitory activity, with S -configuration isomers showing greater activity than R -configuration ones. Notably, S -3-(3,6-di- tert -butyl-9 H -carbazol-9-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoic acid ( 7r- S ) and S -3-(1,3,6-trichloro-9 H -carbazol-9-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoic acid ( 7t- S ) exhibited significant DNMT1 enzyme inhibition activity, with IC 50 values of 8.147 μM and 0.777 μM, respectively (compared to RG108 with an IC 50 above 250 μM). Moreover, they demonstrated potential anti-proliferative activity on various tumor cell lines including A2780, Hela, K562, and SiHa. Transcriptome analysis and KEGG pathway enrichment of K562 cells treated with 7r- S and 7t- S identified differentially expressed genes (DEGs) related to apoptosis and cell cycle pathways. Flow cytometry assays further indicated that 7r- S and 7t- S induce apoptosis in K562 cells and arrest them in the G0/G1 phase in a concentration-dependent manner. Molecular docking revealed that 7t- S may bind to the methyl donor S -adenosyl-l-methionine (SAM) site in DNMT1 with an orientation opposite to RG108, suggesting potential for deeper penetration into the DNMT1 pocket and laying the groundwork for further modifications.

Irreversible Inhibition of DNMT3A by an N‐Mustard Analog of S‐Adenosyl‐L‐methionine

Irreversible Inhibition of DNMT3A by an N-Mustard Analog of S-Adenosyl-L-methionine

A single amino acid substitution confers enhanced methylation activity of mammalian Dnmt3b on chromatin DNA.

AID/APOBEC Deaminases Disfavor Modified Cytosines Implicated in DNA Demethylation

Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation

Revealing Drivers for Carboxy- S-adenosyl-l-methionine Use by Neomorphic Variants of a DNA Methyltransferase

Comprehensive Structure-Function Characterization of DNMT3B and DNMT3A Reveals Distinctivede Novodna Methylation Mechanisms

Identification of 3-(9 H -carbazol-9-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoic acids as promising DNMT1 inhibitors

Discovery of novel non-nucleoside inhibitors with high potency and selectivity for DNA methyltransferase 3A

A Potent Cell-active Allosteric Inhibitor of Murine DNA Cytosine C5 Methyltransferase*

DNA Methyltransferase Inhibitors and Their Therapeutic Potential.

Cytosine analogues as DNA methyltransferase substrates

Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanisms

Structure and Mechanism of DNMT3A‐mediated DNA Methylation

Structural Basis for DNMT3A-mediated De Novo DNA Methylation.

In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1

Insights into the Inhibitory Mechanisms of the Covalent Drugs for DNMT3A

Unveiling the methyl transfer mechanisms in the epigenetic machinery DNMT3A-3 L: A comprehensive study integrating assembly dynamics with catalytic reactions

DNA Methyltransferase Inhibitors and Their Therapeutic Potential

[Synthesis and application of the methyl analogues of S-adenosyl-L-methionine]

Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy